
Criticism of pricing policy in Europe: meager income cloud Novartis’ shareholder wellness
Criticism of pricing policy in Europe Meager revenues cloud Novartis’ shareholder wellness 2/1/2023, 6:17 p.m Novartis flatters its shareholders with a higher dividend and additional billions for a possible share buyback. But on the stock exchange, this initially does not trigger any storms of jubilation. The reason for this is the missed expectations in the…